Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

HARFORD MEMORIAL HOSPITAL, INC.

NPI: 1770589533 · HAVRE DE GRACE, MD 21078 · General Acute Care Hospital · NPI assigned 06/24/2005

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official PRIOLO, MARCUS controls 16+ related entities in our dataset. Read more

$2.03M
Total Medicaid Paid
31,146
Total Claims
25,362
Beneficiaries
46
Codes Billed
2018-01
First Month
2024-01
Last Month

Provider Details

Authorized OfficialPRIOLO, MARCUS (CFO)
NPI Enumeration Date06/24/2005

Related Entities

Other providers sharing the same authorized official: PRIOLO, MARCUS

ProviderCityStateTotal Paid
UPPER CHESAPEAKE MEDICAL SERVICES, INC BEL AIR MD $2.91M
UPPER CHESAPEAKE MEDICAL CENTER, INC. BEL AIR MD $1.57M
HARFORD PRIMARY CARE LLC BEL AIR MD $880K
UPPER CHESAPEAKE CARDIOLOGY, LLC BEL AIR MD $565K
UPPER CHESAPEAKE PRIMARY CARE,LLC BEL AIR MD $480K
UPPER CHESAPEAKE WOMENS CARE, LLC BEL AIR MD $459K
UPPER CHESAPEAKE MEDICAL SERVICES, INC. ABERDEEN MD $363K
UPPER CHESAPEAKE HEMATOLOGY AND ONCOLOGY SERVICES, LLC BEL AIR MD $184K
HARFORD CRISIS CENTER, INC. BEL AIR MD $116K
UPPER CHESAPEAKE ENDOCRINOLOGY ASSOCIATES, LLC ABERDEEN MD $106K
UPPER CHESAPEAKE ORTHOPEDICS, LLC BEL AIR MD $75K
UPPER CHESAPEAKE SURGICAL ASSOCIATES, LLC BEL AIR MD $53K
UPPER CHESAPEAKE CRITICAL CARE ASSOCIATES, LLC BEL AIR MD $52K
HARFORD CRISIS CENTER, INC. BEL AIR MD $37K
UPPER CHESAPEAKE RADIATION ONCOLOGY, LLC ABERDEEN MD $11K
UPPER CHESAPEAKE MEDICAL CENTER, INC. ABERDEEN MD $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 7,536 $673K
2019 7,779 $818K
2020 3,583 $120K
2021 5,089 $170K
2022 3,739 $116K
2023 3,210 $120K
2024 210 $10K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
41899 Unlisted procedure, dentoalveolar structures 231 221 $1.36M
99284 Emergency department visit for the evaluation and management, high severity 2,739 2,448 $298K
G0378 Hospital observation service, per hour 416 369 $116K
99283 Emergency department visit for the evaluation and management, moderate severity 1,530 1,392 $102K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2,028 1,666 $89K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 241 228 $49K
80053 Comprehensive metabolic panel 3,805 3,099 $4K
71046 Radiologic examination, chest; 2 views 639 586 $3K
93793 178 100 $1K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1,092 871 $1K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,521 3,328 $1K
70450 Computed tomography, head or brain; without contrast material 490 440 $940.90
74177 Computed tomography, abdomen and pelvis; with contrast material 83 76 $826.39
71045 Radiologic examination, chest; single view 1,299 1,162 $583.47
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 22 15 $484.63
84484 1,564 1,157 $434.31
J7050 Infusion, normal saline solution, 250 cc 482 232 $392.83
96127 104 100 $250.10
81001 859 783 $233.45
99281 Emergency department visit for the evaluation and management, self-limited or minor 623 555 $205.22
83735 2,341 1,922 $191.51
83690 685 600 $133.33
85610 1,168 798 $105.61
80048 Basic metabolic panel (calcium, ionized) 580 451 $95.86
74176 Computed tomography, abdomen and pelvis; without contrast material 17 16 $85.11
84703 72 64 $42.94
J7030 Infusion, normal saline solution , 1000 cc 724 557 $32.92
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 62 55 $31.88
81003 192 179 $31.54
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 57 56 $30.41
82150 270 240 $19.65
J1650 Injection, enoxaparin sodium, 10 mg 81 43 $14.82
J8499 Prescription drug, oral, non chemotherapeutic, nos 65 52 $12.08
J1885 Injection, ketorolac tromethamine, per 15 mg 385 302 $10.56
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 345 312 $7.96
J2405 Injection, ondansetron hydrochloride, per 1 mg 178 127 $1.84
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 87 78 $0.00
87086 Culture, bacterial; quantitative colony count, urine 39 37 $0.00
83036 Hemoglobin; glycosylated (A1C) 27 26 $0.00
84443 Thyroid stimulating hormone (TSH) 14 13 $0.00
99282 Emergency department visit for the evaluation and management, low to moderate severity 18 17 $0.00
85730 18 12 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 661 487 $0.00
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 55 39 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 16 12 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 43 39 $0.00